Endoplasmic Stress Inhibitors for Homocysteine Induced Cardiovascular Disease

Area of Science:

• Biomedical science
• Cardiovascular research
• Cellular biology

Background:

• Cardiovascular disease (CVD) is a leading global cause of mortality and morbidity.
• Current pharmacological interventions for CVD have limitations.
• Novel therapeutic strategies targeting cellular stress pathways are needed.

Purpose of the Study:

• To review the role of homocysteine in cardiovascular disease.
• To examine the connection between endoplasmic reticulum stress and mitochondrial dysfunction in CVD.
• To explore potential therapeutic avenues targeting these pathways.

Main Methods:

• Literature review of scientific articles.
• Analysis of cellular stress pathways.
• Investigation of mitochondria function.
• Exploration of homocysteine and endoplasmic reticulum stress links.

Main Results:

• Homocysteine is implicated in CVD pathogenesis.
• Endoplasmic reticulum stress impacts mitochondrial function.
• These interconnected pathways represent potential therapeutic targets.

Conclusions:

• Targeting homocysteine and endoplasmic reticulum stress pathways offers a promising therapeutic strategy for CVD.
• Further research into these cellular mechanisms could lead to effective treatments.
• Inhibition of novel cellular stress pathways may provide a new avenue for CVD management.